Holen Sie sich die Stockscreener-App
2.70
1.51%
0.05
Schlusskurs vom Vortag:
$2.65
Offen:
$2.73
24-Stunden-Volumen:
123.93K
Relative Volume:
0.03
Marktkapitalisierung:
$385.88M
Einnahmen:
$4.21M
Nettoeinkommen (Verlust:
$-97.67M
KGV:
-2.9032
EPS:
-0.93
Netto-Cashflow:
$-70.76M
1W Leistung:
-12.38%
1M Leistung:
+15.95%
6M Leistung:
-33.25%
1J Leistung:
-46.20%
1-Tages-Spanne:
$2.67
$2.76
1-Wochen-Bereich:
$2.64
$3.155
52-Wochen-Spanne:
$2.01
$6.33
Absci Corp Stock (ABSI) Company Profile
Firmenname
Absci Corp
Sektor
Branche
Telefon
(360) 949-1041
Adresse
18105 SE MILL PLAIN BLVD, VANCOUVER
Vergleichen Sie ABSI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ABSI
Absci Corp
|
2.6997 | 385.88M | 4.21M | -97.67M | -70.76M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 129.44B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
565.78 | 61.42B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
624.44 | 38.44B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
270.90 | 33.29B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
234.88 | 26.95B | 3.81B | -644.79M | -669.77M | -6.24 |
Absci Corp Stock (ABSI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-22 | Eingeleitet | Needham | Buy |
| 2024-10-02 | Eingeleitet | Guggenheim | Buy |
| 2024-07-03 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-03-14 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-12-05 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2023-05-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-08-12 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2022-07-18 | Eingeleitet | Truist | Buy |
| 2022-03-02 | Fortgesetzt | Cowen | Market Perform |
| 2022-02-01 | Eingeleitet | Berenberg | Buy |
| 2021-11-10 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-08-16 | Eingeleitet | BofA Securities | Neutral |
| 2021-08-16 | Eingeleitet | Cowen | Market Perform |
| 2021-08-16 | Eingeleitet | Credit Suisse | Outperform |
| 2021-08-16 | Eingeleitet | Stifel | Hold |
Alle ansehen
Absci Corp Aktie (ABSI) Neueste Nachrichten
Marshall Wace LLP Reduces Stock Position in Absci Co. (NASDAQ:ABSI) - MarketBeat
128,400 Shares in Absci Co. (NASDAQ:ABSI) Acquired by Jump Financial LLC - MarketBeat
Absci (NASDAQ:ABSI) Stock Price Expected to Rise, KeyCorp Analyst Says - MarketBeat
Absci price target raised to $9 from $5 at KeyBanc - TipRanks
Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025 - GlobeNewswire
AI Drug Pioneer Absci Reveals Q1 2025 Results Date: Key Updates Coming May 13 - Stock Titan
Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testing - Benzinga
Raymond James Financial Inc. Acquires Shares of 193,926 Absci Co. (NASDAQ:ABSI) - MarketBeat
Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday - Benzinga
Absci (NASDAQ:ABSI) Earns Buy Rating from Needham & Company LLC - MarketBeat
Health Care Technology Stocks Surge After FDA Announces Plans To Phase Out Animal Testing Requirements - Benzinga
Absci Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)Absci (NASDAQ:ABSI) - Benzinga
ADAR1 Capital Management LLC Has $413,000 Position in Absci Co. (NASDAQ:ABSI) - MarketBeat
Absci Corporation: A Potential Turnaround Play In Biotech Amid A Tumultuous Market - Seeking Alpha
Top 5 AI & Digital Biotech Companies (April 2025) - Securities.io
Absci stock touches 52-week low at $2.45 amid market challenges - Investing.com
Absci stock touches 52-week low at $2.45 amid market challenges By Investing.com - Investing.com South Africa
Which Healthcare Stock Is the Best Buy Right Now? - MarketBeat
Absci to Participate in Upcoming Investor Conferences - GlobeNewswire
AI Drug Pioneer Absci Takes Center Stage at Two Elite Healthcare Conferences - Stock Titan
Royce & Associates LP Grows Stake in Absci Co. (NASDAQ:ABSI) - MarketBeat
HC Wainwright Issues Negative Estimate for Absci Earnings - MarketBeat
Absci Corp’s Earnings Call: Balancing Innovation and Financial Challenges - MSN
KeyBanc maintains Absci stock Overweight rating, $5 target By Investing.com - Investing.com South Africa
KeyBanc maintains Absci stock Overweight rating, $5 target - Investing.com
Platinum Investment Management Ltd. Boosts Holdings in Absci Co. (NASDAQ:ABSI) - MarketBeat
Absci (NASDAQ:ABSI) Given "Buy" Rating at HC Wainwright - MarketBeat
Absci (NASDAQ:ABSI) Given Buy Rating at Needham & Company LLC - MarketBeat
Absci (NASDAQ:ABSI) Releases Quarterly Earnings Results - MarketBeat
Absci (NASDAQ:ABSI) Announces Earnings Results - MarketBeat
Absci Corporation (NASDAQ:ABSI) Q4 2024 Earnings Call Transcript - Insider Monkey
Cathie Wood's Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While Offloading Illumina And Amgen - Benzinga
Absci Corp (ABSI) Q4 2024: Everything You Need To Know Ahead Of Earnings - GuruFocus
Nikko Asset Management Americas Inc. Boosts Stock Position in Absci Co. (NASDAQ:ABSI) - MarketBeat
H.C. Wainwright maintains $7 target on Absci stock with Buy rating - Investing.com Australia
Finanzdaten der Absci Corp-Aktie (ABSI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Absci Corp-Aktie (ABSI) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Jonasson Zachariah | CFO / CBO |
Jun 13 '24 |
Sale |
4.98 |
19,859 |
98,892 |
384,751 |
| Phoenix Venture Partners II LP | 10% Owner |
May 22 '24 |
Sale |
4.40 |
3,100,000 |
13,640,000 |
11,279,522 |
3.34%
0.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):